BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Monday reported third-quarter net income of $1.05 billion.

On a per-share basis, the Boston-based company said it had net income of $4.01. Earnings, adjusted for stock option expense and non-recurring costs, came to $4.38 per share.

The results topped Wall Street expectations. The average estimate of 13 analysts surveyed by Zacks Investment Research was for earnings of $4.13 per share.

The drugmaker posted revenue of $2.77 billion in the period, which also beat Street forecasts. Eleven analysts surveyed by Zacks expected $2.67 billion.

Vertex expects full-year revenue in the range of $10.8 billion to $10.9 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VRTX at https://www.zacks.com/ap/VRTX